Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cells
Open accessThe DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Abstract
We recently reported that differentiation of CD8(+) T cells from the naïve to the effector state involves the upregulation of glucose-dependent metabolism. Glucose deprivation or inhibition of glycolysis by 2-deoxy-D-glucose (2-DG) selectively inhibited production of IFN-gamma but not of IL-2. To determine a more global role of glucose metabolism on effector T-cell function, we performed gene array analysis on CD8(+) effector T cells stimulated in the presence or absence of 2-DG. We observed that expression of only 10% of genes induced by TCR/CD28 signaling was inhibited by 2-DG. Among these were genes for key cytokines, cell cycle molecules, and cytotoxic granule proteins. Consistent with these results, production of IFN-gamma and GM-CSF, cell cycle progression, upregulation of cyclin D2 protein, cytolytic activity, and upregulation of granzyme B protein and also conjugate formation were exquisitely glucose-dependent. In contrast to glucose, oxygen was little utilized by CD8(+) effector T cells, and relative oxygen deprivation did not inhibit these CTL functional properties. Our results indicate a particularly critical role for glucose in regulating specific effector functions of CD8(+) T cells and have implications for the maintenance of the effector phase of cellular immune responses in target tissue microenvironments such as a solid tumor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Reduction in mTOR activity diminishes IFNγ transcripts in T cells, mitigating Th1 CD4+ T cell differentiation [227, 228, 229].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [227]
In the citing paper
“Limiting glucose levels leads to cellular competition; this impairs T‐cell function via decreased mTOR signaling.”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [227]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nicoletti, I., Migliorati, G., Pagliacci, M. C., Grignani, F., & Riccardi, C. (1991) · Journal of Immunological Methods · doi:10.1016/0022-1759(91)90198-o · Cited by 4,579 · cited 1×
“To determine which phase of the cell cycle is blocked by 2-DG, we examined the DNA content of stimulated effector cells by PI staining (Nicoletti assay) [6].”
MethodModel-based analysis of oligonucleotide arrays: Expression index computation and outlier detection.
Li, C., & Wong, W. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.31 · Cited by 3,133 · cited 1×
“Subsequent data analysis involved: i) the normalization of array values by dCHIP software [29], ii) the averaging of two independent samples for each experiment, iii) determining relative expression using normalized values in a Microsoft Excel spreadsheet.”
MethodThree-dimensional segregation of supramolecular activation clusters in T cells
Monks, C. R. F., Freiberg, B. A., Kupfer, H., Sciaky, N., & Kupfer, A. (1998) · Nature · doi:10.1038/25764 · Cited by 1,968 · cited 1×
“In addition, the mature synapse in many systems includes central clearing of talin and partitioning of signaling molecules such as PKC-θ in the central supramolecular activation cluster (cSMAC) [5].”
BackgroundAMP-activated protein kinase induces a p53-dependent metabolic checkpoint
Jones, R. G., Plas, D. R., Kubek, S., Buzzai, M., Mu, J., Xu, Y., Birnbaum, M. J., & Thompson, C. B. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.027 · Cited by 1,619
The Role of Oxidative Stress in Carcinogenesis
Klaunig, J. E., & Kamendulis, L. M. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121851 · Cited by 1,533 · cited 1×
“It is well-established that ROS induce DNA damage and can lead to aberrant activation of AP-1 and NF-κB [22].”
BackgroundMolecular and Functional Profiling of Memory CD8 T Cell Differentiation
Kaech, S. M., Hemby, S., Kersh, E., & Ahmed, R. (2002) · Cell · doi:10.1016/s0092-8674(02)01139-x · Cited by 982 · cited 1×
“expression of glycolytic enzyme genes in effector and memory T cells analyzed ex vivo [20].”
BackgroundFuel feeds function: energy metabolism and the T-cell response
Fox, C. J., Hammerman, P. S., & Thompson, C. B. (2005) · Nature Reviews Immunology · doi:10.1038/nri1710 · Cited by 853 · cited 1×
“The role of cell metabolism in T cell responsiveness to TCR/CD28 ligation has recently been reviewed [3].”
BackgroundThe Immunological Synapse of CTL Contains a Secretory Domain and Membrane Bridges
Stinchcombe, J. C., Bossi, G., Booth, S., & Griffiths, G. M. (2001) · Immunity · doi:10.1016/s1074-7613(01)00234-5 · Cited by 814
Localization of the primary metabolic block produced by 2-deoxyglucose
Wick, A. N., Drury, D. R., Nakada, H. I., Wolfe, J. B., Britton, B., & Grabowski, R. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64988-9 · Cited by 780 · cited 1×
“5-SHG and 2-DG are both competitive inhibitors of glucose for the glycolytic proteins hexokinase, phosphoglucoisomerase, and phosphoglucomutase [8,9].”
BackgroundRegulation of immune cells by local-tissue oxygen tension: HIF1α and adenosine receptors
Sitkovsky, M., & Lukashev, D. (2005) · Nature Reviews Immunology · doi:10.1038/nri1685 · Cited by 518 · cited 1×
“Hypoxic conditions are known to induce upregulation of HIF-1α, which promotes expression of genes encoding glycolytic enzymes but also has other physiologic targets [17].”
Background
Cited by
Items 101–200 of 387
(2014) · Advances in Cancer Research · doi:10.1016/b978-0-12-800249-0.00002-0 · Cited by 104
“One of the major reasons for the limited success of therapeutic cancer vaccines to date is likely to be the negative influence of the tumor microenvironment and other immunosuppressive factors (Cham et al., 2008; Gajewski et al., 2006a; Gajewski et al., 2006b).”
BackgroundVitamin D endocrinology on the cross-road between immunity and metabolism
Vanherwegen, A.-S., Gysemans, C. A., & Mathieu, C. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.04.018 · Cited by 117
Autophagy inhibition in cancer therapy: metabolic considerations for antitumor immunity
Townsend, K. N., Hughson, L. R. K., Schlie, K., Poon, V. I., Westerback, A., & Lum, J. J. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01141.x · Cited by 102
“Inhibits Lck signaling in T cells (97), thus decreases T cell receptor activation and induction of glycolysis (106-108) Treg cells do not rely as heavily on glycolysis therefore they may not be as affected by imatinib treatment (109, 110).”
BackgroundZhang, Y., & Ertl, H. C. J. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00032 · Cited by 102
Coloff, J. L., Mason, E. F., Altman, B. J., Gerriets, V. A., Liu, T., Nichols, A. N., Zhao, Y., Wofford, J. A., Jacobs, S. R., Ilkayeva, O., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.179101 · Cited by 100
Ottensmeier, C. H., Perry, K. L., Harden, E. L., Stasakova, J., Jenei, V., Fleming, J., Wood, O., Woo, J., Woelk, C. H., Thomas, G. J., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3121 · Cited by 99
Cytotoxic CD4 T Cells: Differentiation, Function, and Application to Dengue Virus Infection
Tian, Y., Sette, A., & Weiskopf, D. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00531 · Cited by 106
“For instance, glucose and glycolysis promote the expression of cytotoxic molecules in CD8 T cells (96).”
BackgroundCretenet, G., Clerc, I., Matias, M. I., Loisel‐Meyer, S., Craveiro, M., Oburoglu, L., Kinet, S., Mongellaz, C., Dardalhon, V., & Taylor, N. N. (2016) · Scientific Reports · doi:10.1038/srep24129 · Cited by 104
Modulation of let-7 miRNAs controls the differentiation of effector CD8 T cells
Wells, A. C., Daniels, K. A., Angelou, C. C., Fagerberg, E., Burnside, A., Markstein, M., Alfandari, D., Welsh, R. M., Pobezinskaya, E. L., & Pobezinsky, L. A. (2017) · eLife · doi:10.7554/elife.26398 · Cited by 102
“…function of Myc in activated CD8 T cells is to support the proliferative burst through the metabolic reprogramming of lymphocytes from primarily oxidative phosphorylation (resting) to glycolysis (activated), as well as through an increase in protein synthesis (Cham et al., 2008; Wang et al., 2011).”
BackgroundXie, D., Zhu, S., & Bai, L. (2016) · Science China Life Sciences · doi:10.1007/s11427-016-0348-7 · Cited by 103
“And increased glycolysis has been shown to promote the functions and development of effector CD8 T cells and Th1 cells (Cham et al., 2008; Chang et al., 2013).”
Background4-1BB signaling activates glucose and fatty acid metabolism to enhance CD8+ T cell proliferation
Choi, B. K., Lee, D. Y., Lee, D. G., Kim, Y. H., Kim, S.-H., Oh, H. S., Han, C., & Kwon, B. S. (2016) · Cellular and Molecular Immunology · doi:10.1038/cmi.2016.02 · Cited by 99
Nanomaterial-enabled metabolic reprogramming strategies for boosting antitumor immunity
Ma, M., Zhang, Y., Pu, K., & Tang, W. (2025) · Chemical Society Reviews · doi:10.1039/d4cs00679h · Cited by 107
Clinical significance of T cell metabolic reprogramming in cancer
Herbel, C., Patsoukis, N., Bardhan, K., Seth, P., Weaver, J. D., & Boussiotis, V. A. (2016) · Clinical and Translational Medicine · doi:10.1186/s40169-016-0110-9 · Cited by 102
Cerebral gluconeogenesis and diseases
Yip, J., Geng, X., Shen, J., & Ding, Y. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00521 · Cited by 89
“In tumors, however, the cytotoxic functions of TIL such as IFN-γ, IL-2, IL-17, and granzyme B production are inhibited by multiple environmental factors (Cham et al., 2008; Mellman et al., 2011; Michalek et al., 2011; Shiao et al., 2011; Finlay et al., 2012; Chang et al., 2013).”
BackgroundMetabolism in the Tumor Microenvironment
Lau, A. N., & Heiden, M. G. V. (2019) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030419-033333 · Cited by 96
Mockler, M. B., Conroy, M. J., & Lysaght, J. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00107 · Cited by 88
“Glucose is essential for TEFF cell survival and proliferation (5), IFN-γ production (58), and cytolytic activity via production of granzyme and perforin (59).”
BackgroundActivated lymphocytes as a metabolic model for carcinogenesis
Macintyre, A. N., & Rathmell, J. C. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-5 · Cited by 88
“Importantly, this increase in aerobic glycolysis precedes and has been shown to be essential for the growth and proliferation of stimulated T cells [21-23].”
BackgroundImmunometabolism in cancer at a glance
Singer, K., Cheng, W.-C., Kreutz, M. P., Ho, P., & Siska, P. J. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.034272 · Cited by 92
“Interestingly, non-malignant proliferating cells perform aerobic glycolysis, which is also considered necessary for optimal T-cell function (Cham et al., 2008).”
BackgroundProgressive multifocal leukoencephalopathy in dimethyl fumarate-treated multiple sclerosis patients
Jordan, A., Yang, J., Fisher, C., Racke, M. K., & Mao‐Draayer, Y. (2020) · Multiple Sclerosis Journal · doi:10.1177/1352458520949158 · Cited by 95
Zhao, J., Jin, D., Huang, M., Ji, J., Xu, X., Wang, F., Zhou, L., Bao, B., Jiang, F., Xu, W., et al. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1416472 · Cited by 84
The Tumor Microenvironment Factors That Promote Resistance to Immune Checkpoint Blockade Therapy
Russell, B. L., Sooklal, S. A., Malindisa, S. T., Daka, L. J., & Ntwasa, M. M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.641428 · Cited by 86
“This small subset of genes comprised those involved in effector functions (50).”
BackgroundFighting in a wasteland: deleterious metabolites and antitumor immunity
Watson, M. J., & Delgoffe, G. M. (2022) · Journal of Clinical Investigation · doi:10.1172/jci148549 · Cited by 86
Burgos-Molina, A. M., Santana, T. T., Redondo, M., & Romero, M. J. B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116188 · Cited by 101
“…cytokines, such as IL-10, can inhibit the activity of phosphoinositide 3-kinase (PI3K), a key enzyme in the PI3K/Akt/mTOR pathway, leading to a decrease in Akt phosphorylation and activation, which in turn inhibits mTORC1 activity, a negative regulator of autophagy [35] (Figure 1).”
BackgroundReinert‐Hartwall, L., Honkanen, J. K., Salo, H. M., Nieminen, J. K., Luopajärvi, K., Härkönen, T., Veijola, R., Simell, O., Ilonen, J., Peet, A., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401653 · Cited by 100
Insulin and cancer: a tangled web
Leitner, B. P., Siebel, S., Akingbesote, N. D., Zhang, X., & Perry, R. J. (2022) · Biochemical Journal · doi:10.1042/bcj20210134 · Cited by 84
Champagne, D. P., Hatle, K. M., Fortner, K. A., D’Alessandro, A., Thornton, T. M., Yang, R., Torralba, D., Tomás-Cortázar, J., Jun, Y. W., Ahn, K. H., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.018 · Cited by 76
“Production of some cytokines by effector CD8+ T cells is not affected by strong inhibition of glycolysis (Cham et al., 2008), and cytotoxic activity can take place in the absence of glucose (MacDonald and Koch, 1977).”
InfluentialMetabolism in cancer metastasis: bioenergetics, biosynthesis, and beyond
Teoh, S. T., & Lunt, S. Y. (2017) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1406 · Cited by 87
“For example, T cells engage in aerobic glycolysis,(247) which is required to maintain optimal effector function.(248) Hence, tumors exhibiting the Warburg effect can inhibit T-cell function in two ways: by depleting glucose from the microenvironment,(248,249) or by increasing lactate levels in the microenvironment, wh…”
BackgroundRegulation of glucose metabolism in T cells: new insight into the role of Phosphoinositide 3-kinases
Finlay, D. K. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00247 · Cited by 74
“Thus, limiting glucose availability in activating T cells compromises TCR induced growth and proliferation and also the expression of certain effector molecules such as interferon γ (IFNγ; Cham et al., 2008; Jacobs et al., 2008).”
BackgroundValle-Mendiola, A., & Soto-Cruz, I. (2020) · Cancers · doi:10.3390/cancers12010124 · Cited by 72
TLR-Mediated Innate Production of IFN-γ by CD8+ T Cells Is Independent of Glycolysis
Salerno, F., Guislain, A., Cansever, D., & Wolkers, M. C. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501997 · Cited by 71
“Upon Ag-specific activation, however, T cells undergo an immediate glycolytic switch to meet the energy demands for proliferation and for optimal effector function (46, 47, 59).”
BackgroundHua, Y., Yang, S., Zhang, Y., Li, J., Wang, M., Yeerkenbieke, P., Liao, Q., & Liu, Q. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02925-5 · Cited by 77
“Of clinical relevance, the efficacy of CD8 + T cells against tumors diminishes in a glucose-deprived environment [107].”
BackgroundT cell metabolic reprogramming and plasticity
Slack, M., Wang, T., & Wang, R. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.07.036 · Cited by 68
Palmer, C. S., Duette, G., Wagner, M. C. E., Henstridge, D. C., Saleh, S., Pereira, C. F., Zhou, J., Simar, D., Lewin, S. R., Ostrowski, M., et al. (2017) · FEBS Letters · doi:10.1002/1873-3468.12843 · Cited by 75
Metabolism and autophagy in the immune system: immunometabolism comes of age
Rathmell, J. C. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01158.x · Cited by 77
“How these pathways are regulated and impact T-cell function are still not clear, but blocking glucose or glutamine metabolism can potently inhibit lymphocyte activation and proliferation (35, 47, 88, 89).”
BackgroundCaslin, H. L., Taruselli, M. T., Haque, T. T., Pondicherry, N., Baldwin, E. A., Barnstein, B. O., & Ryan, J. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03026 · Cited by 73
Sculpting tumor microenvironment with immune system: from immunometabolism to immunoediting
Yu, Y.-R., & Ho, P. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13293 · Cited by 69
The tumour microenvironment in pancreatic cancer — new clinical challenges, but more opportunities
Kung, H., Zheng, K., Zimmerman, J. W., & Zheng, L. (2025) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-025-01077-z · Cited by 100
Dual Proteolytic Pathways Govern Glycolysis and Immune Competence
Lü, W., Zhang, Y., McDonald, D., Jing, H., Carroll, B., Robertson, N., Zhang, Q., Griffin, H. R., Sanderson, S., Lakey, J. H., et al. (2014) · Cell · doi:10.1016/j.cell.2014.12.001 · Cited by 73
“…less impairment of glycolytic flux than 2-DG treatment (Lampidis et al., 2006), consonant with ell 159, 1578–1590, December 18, 2014 ª2014 Elsevier Inc. 1587 its selective effect on HK2 that spares oxidative phosphorylation and, hence, T cell proliferation (Cham et al., 2008; Miller et al., 1994).”
Sasaki, K., Nishina, S., 山内, 明., Fukuda, K., Hara, Y., Yamamura, M., Egashira, K., & Hino, K. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.10.010 · Cited by 70
Immune Gene and Cell Enrichment Is Associated with a Good Prognosis in Ependymoma
Donson, A. M., Birks, D. K., Barton, V. N., Wei, Q., Kleinschmidt-DeMasters, B. K., Handler, M. H., Waziri, A. E., Wang, M., & Foreman, N. K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902811 · Cited by 63
“However, the dependence of T-lymphocyte activity on glucose metabolism suggests a potential role in immune function for this gene (29).”
Backgroundde Silly, R. V., Ducimetière, L., Maroun, C. Y., Dietrich, P., Derouazi, M., & Walker, P. R. (2015) · European Journal of Immunology · doi:10.1002/eji.201445284 · Cited by 75
“The impact of hypoxia and oxygen tensions on CD8 + T cells is restricted to a few interesting studies [17, 18, [38] [39] [40] [41] [42] .”
BackgroundHargadon, K. M. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.37 · Cited by 67
Targeting Autophagy to Treat Cancer: Challenges and Opportunities
Lim, J., & Murthy, A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.590344 · Cited by 63
Immunometabolism in biofilm infection: lessons from cancer
Mirzaei, R., Sabokroo, N., Ahmadyousefi, Y., Motamedi, H., & Karampoor, S. (2022) · Molecular Medicine · doi:10.1186/s10020-022-00435-2 · Cited by 63
“Intriguingly, nonmalignant proliferating cells undergo aerobic glycolysis, which is also deemed critical for optimum T-cell activity (Cham et al. 2008).”
BackgroundThe glucose transporter 2 regulates CD8+ T cell function via environment sensing
Fu, H., Vuononvirta, J., Fanti, S., Bonacina, F., d’Amati, A., Wang, G., Poobalasingam, T., Fankhaenel, M., Lucchesi, D., Coleby, R., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00913-9 · Cited by 67
“Also, glucose-deficient CD8 + T cells have impaired cytolytic activity, including reduced granzyme and perforin production 43 .”
Immunometabolism: new insights and lessons from antigen-directed cellular immune responses
Ramalho, R., Rao, M., Zhang, C., Agrati, C., Ippolito, G., Wang, F., Zumla, A. I., & Maeurer, M. J. (2020) · Seminars in Immunopathology · doi:10.1007/s00281-020-00798-w · Cited by 70
“Although differentiation may still occur in this situation, effector clones present reduced effector functions [153, 154].”
BackgroundSodium chloride in the tumor microenvironment enhances T cell metabolic fitness and cytotoxicity
Soll, D., Chu, C.-F., Sun, S., Lutz, V., Arunkumar, M., Gachechiladze, M. A., Schäuble, S., Alissa-Alkhalaf, M., Nguyen, T. T. T., Khalil, M., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01918-6 · Cited by 62
Turbitt, W. J., Rosean, C. B., Weber, K. S., & Norian, L. A. (2020) · Immunological Reviews · doi:10.1111/imr.12849 · Cited by 62
Long-term antigen exposure irreversibly modifies metabolic requirements for T cell function
Bettonville, M., d'Aria, S., Weatherly, K., Porporato, P. E., Zhang, J., Bousbata, S., Sonveaux, P., & Braun, M. Y. (2018) · eLife · doi:10.7554/elife.30938 · Cited by 66
“…does not rely on glycolysis in chronic CD4+ T cells is in sharp contrast with the highly glycolytic metabolic profile generally observed in effector T cells which fail to produce IFNg in the absence of glycolysis (Chang et al., 2013; Gubser et al., 2013; Cham et al., 2008; Cham and Gajewski, 2005).”
BackgroundPatsoukis, N., Weaver, J. D., Strauss, L., Herbel, C., Seth, P., & Boussiotis, V. A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00330 · Cited by 60
“As nutrients and metabolites provide important environmental cues with decisive role in T cell activation (187), it is also possible that distinct metabolic programs of various microenvironments selectively promote the expression and function of different coinhibitory receptors.”
BackgroundNicoli, F., Papagno, L., Frere, J. J., Cabral-Piccin, M. P., Clave, E., Gostick, E., Toubert, A., Price, D. A., Caputo, A., & Appay, V. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02736 · Cited by 61
“Despite this caveat, in vitro priming experiments showed that the expansion and maturation of naïve CD8 T-cells were strongly dependent on glycolysis, consistent with earlier observations in murine models (45).”
ResultLi, X., Zhang, Y., Ma, W., Fu, Q., Liu, J., Yin, G., Chen, P., Dai, D., Chen, W., Qi, L., et al. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-019-02457-y · Cited by 63
Metabolic regulation of T cells in the tumor microenvironment by nutrient availability and diet
Zhao, S., Peralta, R. M., Avina-Ochoa, N., Delgoffe, G. M., & Kaech, S. M. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101485 · Cited by 67
Driessens, G., Zheng, Y., Locke, F., Cannon, J. L., Gounari, F., & Gajewski, T. F. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001562 · Cited by 54
“Primary T cells were activated with beads (Dynal, Carlsbad, CA) coated with anti-CD3 (145-2C11) at 1 mg/ml and anti-CD28 (PV1) 1 mg/ml or PMA (10 ng/ml) and ionomycin (2 mM) and analyzed as described previously for cytokine production and proliferation (32).”
MethodSelf-citationBirkenmeier, K., Dröse, S., Wittig, I., Winkelmann, R., Käfer, V., Döring, C., Hartmann, S., Wenz, T., Reichert, A. S., Brandt, U., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.29934 · Cited by 60
DUSP6 mediates T cell receptor-engaged glycolysis and restrains T FH cell differentiation
Hsu, W.-C., Chen, M.-Y., Hsu, S.-C., Huang, L.-R., Kao, C.-Y., Cheng, W.-H., Pan, C.-H., Wu, M.-S., Yu, G.-Y., Hung, M.-S., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1800076115 · Cited by 53
“7B, Right), which was consistent with earlier reports describing the indispensable role of glycolysis for IFN-γ production (36, 58, 59).”
ResultCerto, M., Elkafrawy, H., Pucino, V., Cucchi, D., Cheung, K. C. P., & Mauro, C. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15002 · Cited by 53
Bioenergetics profile of CD4 + T cells in relapsing remitting multiple sclerosis subjects
Riccardis, L. D., Rizzello, A., Ferramosca, A., Urso, E., Robertis, F. D., Danieli, A., Giudetti, A. M., Trianni, G., Zara, V., & Maffia, M. (2015) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2015.02.015 · Cited by 53
Dynamic Metabolic State of Tissue Resident CD8 T Cells
Konjar, Š., & Veldhoen, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01683 · Cited by 53
“The importance of glycolysis for cytotoxic T cell function was shown using the glycolysis inhibitor 2-deoxyglucose (2DG), resulting in defective T cell cytotoxic capacity and selective reduction of the expression of key effector molecules, including IFN-γ and granzymes (18, 19).”
BackgroundZhang, Y., Lin, A., Li, Y., Ding, W., Meng, H., Luo, P., & Zhang, J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.608969 · Cited by 55
“Aerobic glycolysis is necessary for T cells to differentiate into effector cells (Cham et al., 2008), whereas M2 macrophages rely on fatty acid metabolism (Huang et al.”
BackgroundKang, S., & Tang, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.572677 · Cited by 61
“Besides, glucose-deprivation also inhibits INFg, GM-CSF and TNFa production in CD8+ T cells, completely or partially (42, 43).”
BackgroundLipid and glucose metabolism in senescence
Liu, B., Meng, Q., Gao, X., Sun, H., Xu, Z., Wang, Y., & Zhou, H. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1157352 · Cited by 60
“However, chronic or excessive stimulation can lead to T cell exhaustion or senescence, which are associated with metabolic dysregulation, such as impaired glucose uptake, reduced glycolytic capacity, and altered mitochondrial function (266).”
BackgroundFernández-García, J., Franco, F., Parik, S., Altea‐Manzano, P., Pane, A. A., Broekaert, D., Elsen, J. V., Conza, G. D., Vermeire, I., Schalley, T., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111639 · Cited by 58
Predator-Prey in Tumor-Immune Interactions: A Wrong Model or Just an Incomplete One?
Kareva, I., Luddy, K. A., O’Farrelly, C., Gatenby, R. A., & Brown, J. S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.668221 · Cited by 54
Natural killer cells and type 1 innate lymphoid cells in cancer
Lopes, N., Vivier, É., & Narni-Mancinelli, É. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2022.101709 · Cited by 52
The role of mitochondria in the resistance of melanoma to PD-1 inhibitors
Du, F., Yang, L.-H., Liu, J., Wang, J., Fan, L., Duangmano, S., Liu, H., Liu, M., Wang, J., Zhong, X., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04200-9 · Cited by 54
Metabolic engineering for optimized CAR-T cell therapy
McPhedran, S. J., Carleton, G. A., & Lum, J. J. (2024) · Nature Metabolism · doi:10.1038/s42255-024-00976-2 · Cited by 56
CD73 Ectonucleotidase Restrains CD8+ T Cell Metabolic Fitness and Anti-tumoral Activity
Briceño, P., Rivas-Yáñez, E., Rosemblatt, M. V., Parra-Tello, B., Farías, P., Vargas, L., Simon, V., Cárdenas, C., Lladser, Á., Salazar‐Onfray, F., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.638037 · Cited by 51
“Similarly, it has been described that an increase in aerobic glycolysis promotes the production of other effector molecules, such as granzyme B (Cham and Gajewski, 2005; Cham et al., 2008).”
BackgroundMetabolic regulation of leukocyte motility and migration
Marelli‐Berg, F. M., & Jangani, M. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.1mr1117-472r · Cited by 51
Optical Control of CD8+ T Cell Metabolism and Effector Functions
Amitrano, A. M., Berry, B. J., Lim, K., Kim, K., Waugh, R. E., Wojtovich, A. P., & Kim, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.666231 · Cited by 55
“In earlier studies, 2DG treatment of effector T cells showed a decrease in mitochondrial respiration as well as decreases in other effector functions, including cytokine production and cytolytic activity (13, 31).”
BackgroundMethodPharmacological Targeting of GLUT1 to Control Autoreactive T Cell Responses
Dedda, C. D., Vignali, D., Piemonti, L., & Monti, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194962 · Cited by 49
“Gene array analysis of CD8+ T cells treated with 2-DG showed inhibition of the expression of genes for key cytokines, cell cycle molecules, and cytotoxic granule proteins [31].”
BackgroundThe Role of Metabolic Enzymes in the Regulation of Inflammation
Godfrey, W. H., & Kornberg, M. D. (2020) · Metabolites · doi:10.3390/metabo10110426 · Cited by 51
“The glycolytic inhibitor 2-DG, which indirectly inhibits hexokinase through the competitive inhibition of the downstream enzyme phosphoglucoisomerase, impairs T cell proliferation and effector functions [27,28]; shifts the balance between effector, regulatory, and memory T cells [31,43]; prevents the pro-inflammatory…”
BackgroundImmunometabolism: crosstalk with tumor metabolism and implications for cancer immunotherapy
Zhang, H., Fan, J., Kong, D., Sun, Y., Zhang, Q., Xiang, R., Lu, S., Yang, W., Feng, L., & Zhang, H. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02460-1 · Cited by 58
“Similarly, glucose deprivation inhibits glycolysis in T cells, leading to the inability of T cells to perform effector functions [271–273].”
Sugar or Fat?—Metabolic Requirements for Immunity to Viral Infections
Shehata, H. M., Murphy, A. J., Lee, M. K. S., Gardiner, C. M., Crowe, S. M., Sanjabi, S., Finlay, D. K., & Palmer, C. S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01311 · Cited by 50
“However, upon encountering antigen, Teff development requires a reprogramming to glycolysis that is accompanied by, and supports, rapid proliferation (clonal expansion) and acquisition of specialized effector functions (cytokine production and cytotoxicity) (16, 28).”
BackgroundCiciarello, M., Corradi, G., Forte, D., Cavo, M., & Curti, A. (2021) · Cancers · doi:10.3390/cancers13215319 · Cited by 48
“Overall, metabolic remodeling of the BM microenvironment by AML cells favors the induction and the survival of immune-regulatory cells, such as Tregs [144].”
BackgroundDiet, nutrient supply, and tumor immune responses
McIntyre, C., Temesgen, A., & Lynch, L. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.06.003 · Cited by 46
Ma, G., Li, C., Zhang, Z., Liang, Y., Liang, Z., Chen, Y., Wang, L., Li, D., Zeng, M., Shan, W., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.697894 · Cited by 49
Sheldon, R. D., Ma, E. H., DeCamp, L. M., Williams, K. S., & Jones, R. G. (2021) · Nature Protocols · doi:10.1038/s41596-021-00586-2 · Cited by 43
The role of metabolic reprogramming in T cell fate and function.
Patsoukis, N., Bardhan, K., Weaver, J. D., Herbel, C., Seth, P., Li, L., & Boussiotis, V. A. (2016) · PubMed · Cited by 54
Blockade of N -Glycosylation Promotes Antitumor Immune Response of T Cells
Sasawatari, S., Okamoto, Y., Kumanogoh, A., & Toyofuku, T. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900937 · Cited by 42
“T cells cultured without glucose or with reduced glycolytic activity express low levels of cytotoxic molecules such as perforin and granzyme (8, 20, 21).”
BackgroundManipulating T-cell metabolism to enhance immunotherapy in solid tumor
Chen, C., Wang, Z., Ding, Y., & Qin, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1090429 · Cited by 49
Metabolites and Immune Response in Tumor Microenvironments
Cortellino, S., & Longo, V. D. (2023) · Cancers · doi:10.3390/cancers15153898 · Cited by 45
“The cytotoxic activity of NK cells also depends on glucose metabolism; thus, the lack of glucose impairs the production and release of Ifng and cytotoxic perforins and granzymes [188] (Figure 3).”
Immunological Mechanisms of Sickness Behavior in Viral Infection
Krapić, M., Kavazović, I., & Wensveen, F. M. (2021) · Viruses · doi:10.3390/v13112245 · Cited by 44
“Similarly, depletion of glucose inhibits production of IFN-γ, perforin, granzyme, and proliferation by activated T cells and NK cells [57].”
BackgroundDu, M., Yu, T., Zhan, Q., Li, H., Zou, Y., Geng, M., Meng, T., & Xie, Z. (2022) · Cancer Science · doi:10.1111/cas.15468 · Cited by 43
Metabolic plasticity in heterogeneous pancreatic ductal adenocarcinoma
Liang, C., Qin, Y., Zhang, B., Ji, S., Shi, S., Xu, W., Liu, J., Xiang, J., Liang, D., Hu, Q., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.09.001 · Cited by 41
Regulatory T cells as suppressors of anti-tumor immunity: Role of metabolism
Rosa, V. D., Rella, F. D., Giacomo, A. D., & Matarese, G. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.04.001 · Cited by 39
Metabolic factors contribute to T‐cell inhibition in the ovarian cancer ascites
Gong, Y., Yang, J., Wang, Y., Xue, L., & Wang, J. (2020) · International Journal of Cancer · doi:10.1002/ijc.32990 · Cited by 46
Udumula, M. P., Singh, H., Rashid, F., Poisson, L., Tiwari, N., Dimitrova, I. K., Hijaz, M., Gogoi, R. P., Swenor, M., Munkarah, A. R., et al. (2023) · iScience · doi:10.1016/j.isci.2023.107839 · Cited by 49
“In studies such as chronic lymphocytic leukemia, patients have displayed impaired mitochondrial fitness in CD8T cells which led to delay in CAR-T cell efficiency.(34,35) However, modulation of T cell metabolism by IF is unknown.”
BackgroundThe G1/S Specific Cyclin D2 Is a Regulator of HIV-1 Restriction in Non-proliferating Cells
Badía, R., Pujantell, M., Riveira‐Muñoz, E., Puig, T., Torres‐Torronteras, J., Martí, R., Clotet, B., Ampudia, R. M., Vives‐Pi, M., Esté, J. A., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005829 · Cited by 39
Metabolic adaptations of cells at the vascular-immune interface during atherosclerosis
Bonacina, F., Dalt, L. D., Catapano, A. L., & Norata, G. D. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100918 · Cited by 38
“cell cycle proteins and the production of IFNγ and granzyme, in both mouse and human CD8 T cells (Cham et al., 2008; Cham and Gajewski, 2005; Renner et al., 2015).”
BackgroundTargeting of chimeric antigen receptor T cell metabolism to improve therapeutic outcomes
Nanjireddy, P., Olejniczak, S. H., & Buxbaum, N. P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1121565 · Cited by 40
Liang, P., Li, Z., Chen, Z., Chen, Z., Jin, T., He, F., Chen, X., Gou, H., & Yang, K. (2025) · The FASEB Journal · doi:10.1096/fj.202403019r · Cited by 50
“Glucose plays a central role in regulating their effector functions, especially in solid tumor environments, where maintaining cellular immune responses is essential [63].”
Delmastro-Greenwood, M. M., Votyakova, T. V., Goetzman, E. S., Marré, M. L., Previte, D. M., Tovmasyan, A. G., Batinic̈‐Haberle, I., Trucco, M., & Piganelli, J. D. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.5167 · Cited by 39
Kouidhi, S., Noman, M. Z., Kieda, C., Elgaaied, A. B., & Chouaib, S. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00114 · Cited by 36
“Because glucose and glutamine are crucial for T-cell differentiation and function, and their depletion impairs T cells cytolytic activity as well as interferon-γ (IFN-γ) production (58), it is most likely that the highly glycolytic phenotype of BRAF V600E melanoma may be associated with an immunosuppressive microenvir…”
BackgroundThe multifaceted mechanisms of malignant glioblastoma progression and clinical implications
Sun, R., & Kim, A. H. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10051-5 · Cited by 45
Immunometabolic reprogramming, another cancer hallmark
Kumar, V., & Stewart, J. H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1125874 · Cited by 37
Hematopoietic versus Solid Cancers and T Cell Dysfunction: Looking for Similarities and Distinctions
Montironi, C., Muñoz‐Pinedo, C., & Eldering, E. (2021) · Cancers · doi:10.3390/cancers13020284 · Cited by 40
Immunometabolism at the Nexus of Cancer Therapeutic Efficacy and Resistance
Traba, J., Sack, M. N., Waldmann, T. A., & Antón, O. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.657293 · Cited by 43
“Inhibition of glycolysis also decreases the expression of perforin and granzymes, and blocks cytolytic activity in CD8 cells (67).”
BackgroundSemeniuk-Wojtaś, A., Poddębniak-Strama, K., Modzelewska, M., Baryła, M., Dziąg-Dudek, E., Syryło, T., Górnicka, B., Jakieła, A., & Stec, R. (2023) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-023-03376-9 · Cited by 35
“Because differentiated CD8+ T cells show increased glucose-dependent metabolism compared with naïve cells, glucose deprivation negatively influences effector functions in CD8+ T cells, resulting in impaired effector functions and possibly limited response to immune checkpoint therapy [107, 108].”
BackgroundImmune Resistance Mechanisms and the Road to Personalized Immunotherapy
Piper, M., Kluger, H. M., Ruppin, E., & Hu‐Lieskovan, S. (2023) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_390290 · Cited by 43
Metadata
- Authors
- Cham, C. M., Driessens, G., O'Keefe, J. P., & Gajewski, T. F.
- Affiliations
- University of Chicago (US)
- Corresponding author
- Gajewski, Thomas F.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2008-09
- Volume
- 38
- Issue
- 9
- Pages
- 2438-2450
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- PMC
- PMC3008428
- OpenAlex
- W2156145814
- Cited by
- 388
- References
- 33
- Citations by year
- 2026: 21 · 2025: 28 · 2024: 34 · 2023: 42 · 2022: 34 · 2021: 35 · 2020: 42 · 2019: 24 · 2018: 22 · 2017: 29 · 2016: 21 · 2015: 15 · 2014: 10 · 2013: 8 · 2012: 10
- FWCI
- 1.82
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01 AI47919, R01AI047919)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- glucose deprivation, CD8+ T cells, effector T cells, glycolysis, 2-deoxyglucose, glucose metabolism, interferon-gamma, GM-CSF, granzyme B, cytotoxicity, gene expression, cell cycle progression, cyclin D2, oxygen deprivation, solid tumors, cell-mediated immunity
- MeSH terms
- Animals, Cytotoxicity, Immunologic, Deoxyglucose, Glucose, Lymphocyte Activation, Oxygen, Gene Expression, Cytokines, CD8-Positive T-Lymphocytes, Gene Expression Profiling, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.